Qian Huang

Dr. Qian Huang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
YCYuan Chen
Yuan Chen
XLXinfang Li
Xinfang Li
RSRan Sun
Ran Sun
JJJiamin Ji
Jiamin Ji
FYFan Yang
Fan Yang
QHQian Huang
Qian Huang
Background: Cuproptosis, a genetic process of copper-dependent cell death linked to mitochondria respiration, demonstrates its correlation with inhibiting tumoral angiogenesis and motility. Recent studies have developed systematic bioinformatics frameworks to identify the association of cuproptosis with tumors but any non-neoplastic diseases. Therefore, against the background of an increased incidence of inflammatory bowel disease (IBD), the landscape of cuproptosis regulation in IBD is a critical need to be investigated.Methods: The differentially expressed cuproptosis-related genes (DECRGs) were identified with human sequencing profiles for four inflammatory digestive disorders. Another four independent IBD datasets from GEO were used as a validation cohort. And experimental mice model provides another validation method. Using single sample gene set enrichment analysis (ssGSEA), receiver operating characteristic (ROC) curve, CIBERSORT, and consensus clustering algorithms, we explored the association between immune score and cuproptosis-related genes, as well as the diagnostic value of these genes. Molecular docking screened potential interaction of IBD drugs with the structural regulator by Autodock Vina.Results: Cuproptosis-related regulators exhibited extensive differential expression in Crohn’s Disease (CD), Ulcerative Colitis (UC), Celiac Disease (CEL), and IBD-induced cancer (IBD-CA) that share common differential genes (PDHA1, DBT, DLAT, LIAS). The differential expression of DECRGs was reverified in the validated cohort and immunohistochemistry assay. Moreover, the cell signaling pathways and ontology mainly focused on the mitochondrial respiratory function, which was highly enriched in Gene set enrichment analysis (GSEA). According to ssGSEA and ROC, when considering the four regulators, which showed robust association with immune infiltration in IBD, the area under the ROC (AUC) was 0.743. In addition, two clusters of consensus clustering based on the four regulators exhibit different immune phenotypes. According to molecular docking results, methotrexate gained the highest binding affinity to the main chain of key cuproptosis-related regulators compared with the remaining ten drugs.Conclusion: Cuproptosis-related regulators were widely linked to risk variants, immune cells, immune function, and drug efficacy in IBD. Regulation of cuproptosis may deeply influence the occurrence and development of patients with IBD.

18 February 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
RSRan Sun
Ran Sun
LLLei Lei
Lei Lei
JJJiamin Ji
Jiamin Ji
YCYuan Chen
Yuan Chen
WTWeiliang Tian
Weiliang Tian
QHQian Huang
Qian Huang

15 July 2025 in Journal of Pineal Research
Verified
Journal Article
Closed access
ZZZhirong Zhao
Zhirong Zhao
JJJiamin Ji
Jiamin Ji
LMLan Ming
Lan Ming
ZLZhaofeng Luo
Zhaofeng Luo
MLMingyi Li
Mingyi Li
QHQian Huang
Qian Huang

25 January 2024 in IUBMB Life
Verified
Journal Article
Closed access
YCYuan Chen
Yuan Chen
XLXinfang Li
Xinfang Li
RSRan Sun
Ran Sun
FYFan Yang
Fan Yang
WTWeiliang Tian
Weiliang Tian
QHQian Huang
Qian Huang

15 February 2024 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
ZZZhirong Zhao
Zhirong Zhao
LHLi Han
Li Han
MXMei Xin
Mei Xin
LZLichen Zhou
Lichen Zhou
KJKexin Jiang
Kexin Jiang
RDRuiwu Dai
Ruiwu Dai
Our previous study confirmed that umbilical cord mesenchymal stem cells‐exosomes (ucMSC‐Ex) inhibit apoptosis of pancreatic acinar cells to exert protective effects. However, the relationship between apoptosis and autophagy in traumatic pancreatitis (TP) has rarely been reported. We dissected the transcriptomics after pancreatic trauma and ucMSC‐Ex therapy by high‐throughput sequencing. Additionally, we used rapamycin and MHY1485 to regulate mTOR. HE, inflammatory factors and pancreatic enzymatic assays were used to comprehensively determine the local versus systemic injury level, fluorescence staining and electron microscopy were used to detect the effect of autophagy, and observe the expression levels of autophagy‐related markers at the gene and protein levels. High‐throughput sequencing identified that autophagy played a crucial role in the pathophysiological process of TP and ucMSC‐Ex therapy. The results of electron microscopy, immunofluorescence staining, polymerase chain reaction and western blot suggested that therapeutic effect of ucMSC‐Ex was mediated by activation of autophagy in pancreatic acinar cells through inhibition of mTOR. ucMSC‐Ex can attenuate pancreas injury by inhibiting mTOR to regulate acinar cell autophagy after TP. Future studies will build on the comprehensive sequencing of RNA carried by ucMSC‐Ex to predict and verify specific non‐coding RNA.

27 October 2025 in Journal of Ethnopharmacology
Verified
Journal Article
Open access
LMLan Ming
Lan Ming
JJJiaMin Ji
JiaMin Ji
ZLZhaoFeng Luo
ZhaoFeng Luo
ZZZhiRong Zhao
ZhiRong Zhao
MLMingYi Li
MingYi Li
QHQian Huang
Qian Huang
Ulcerative colitis (UC) is a chronic inflammatory disorder of the colon associated with symptoms of abdominal pain, diarrhea, and rectal bleeding. Sishen Pill (SSP), a classical formulation documented in "The Secret Biography of Hua Tuo Divine Doctors ", has been widely utilized for over 1600 years in the treatment of gastrointestinal disorders, yet its precise pharmacological mechanisms require systematic elucidation. The therapeutic efficacy of SSP in UC and its underlying pathways were investigated using integrative approaches. The phytochemical components of SSP were evaluated using UPLC-MS/MS. A mouse UC model was developed using 72 male C57BL/6 mice administered 2.5 % dextran sulfate sodium (DSS) to evaluate SSP's therapeutic effects. Comprehensive assessments included clinical manifestations (changes in body weights, colon lengths, and disease activity indices), systemic inflammatory responses (serum IL-6, IL-1β, and IL-13 levels), intestinal barrier integrity (occludin and claudin-1 expression via immunohistochemistry), and histopathological changes analyzed by H&E staining. Mechanistic exploration combined RNA sequencing with network pharmacology to identify pivotal pathways, which were further verified in mice and cells using pharmacological interventions and investigating of the AGE-RAGE-NLRP3 axis, respectively. UPLC-MS/MS analysis identified 100 chemical constituents in SSP. The treatment group showed significant mitigation of colitis manifestations compared to DSS controls, including restored body weights and colon lengths, and reduced disease activity indices and histopathological damage. SSP administration lowered production of pro-inflammatory cytokines (IL-6, IL-1β) while increasing that of the anti-inflammatory IL-13, as well as restoration of tight junction protein levels (occludin, claudin-1). Network pharmacology predictions combined with RNA-seq profiling revealed AGE-RAGE-NLRP3 axis as the core regulatory pathway, which was functionally verified through both animal and cell-based experiments. SSP exhibited a protective effect against UC and ameliorated the condition by inhibiting the AGEs-RAGE-NLRP3 signaling pathway.